Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
EULAR points to consider when analysing and reporting comparative effectiveness research using observational data in rheumatology.
Courvoisier DS, Lauper K, Kedra J, de Wit M, Fautrel B, Frisell T, Hyrich KL, Iannone F, Machado PM, Ørnbjerg LM, Rotar Z, Santos MJ, Stamm TA, Stones SR, Strangfeld A, Bergstra SA, Landewé RBM, Finckh A. Courvoisier DS, et al. Among authors: stones sr. Ann Rheum Dis. 2022 Jun;81(6):780-785. doi: 10.1136/annrheumdis-2021-221307. Epub 2022 Jan 20. Ann Rheum Dis. 2022. PMID: 35058229
EULAR/PReS standards and recommendations for the transitional care of young people with juvenile-onset rheumatic diseases.
Foster HE, Minden K, Clemente D, Leon L, McDonagh JE, Kamphuis S, Berggren K, van Pelt P, Wouters C, Waite-Jones J, Tattersall R, Wyllie R, Stones SR, Martini A, Constantin T, Schalm S, Fidanci B, Erer B, Demirkaya E, Ozen S, Carmona L. Foster HE, et al. Among authors: stones sr. Ann Rheum Dis. 2017 Apr;76(4):639-646. doi: 10.1136/annrheumdis-2016-210112. Epub 2016 Nov 1. Ann Rheum Dis. 2017. PMID: 27802961 Free article.
Current status of use of big data and artificial intelligence in RMDs: a systematic literature review informing EULAR recommendations.
Kedra J, Radstake T, Pandit A, Baraliakos X, Berenbaum F, Finckh A, Fautrel B, Stamm TA, Gomez-Cabrero D, Pristipino C, Choquet R, Servy H, Stones S, Burmester G, Gossec L. Kedra J, et al. RMD Open. 2019 Jul 18;5(2):e001004. doi: 10.1136/rmdopen-2019-001004. eCollection 2019. RMD Open. 2019. PMID: 31413871 Free PMC article.
EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseases.
Najm A, Nikiphorou E, Kostine M, Richez C, Pauling JD, Finckh A, Ritschl V, Prior Y, Balážová P, Stones S, Szekanecz Z, Iagnocco A, Ramiro S, Sivera F, Dougados M, Carmona L, Burmester G, Wiek D, Gossec L, Berenbaum F. Najm A, et al. RMD Open. 2019 Sep 13;5(2):e001014. doi: 10.1136/rmdopen-2019-001014. eCollection 2019. RMD Open. 2019. PMID: 31565245 Free PMC article.
2019 EULAR points to consider for the assessment of competences in rheumatology specialty training.
Sivera F, Alunno A, Najm A, Avcin T, Baraliakos X, Bijlsma JW, Badreh S, Burmester G, Cikes N, Da Silva JA, Damjanov N, Dougados M, Dudler J, Edwards CJ, Iagnocco A, Lioté F, Nikiphorou E, van Onna M, Stones SR, Vassilopoulos D, Haines C, Ramiro S. Sivera F, et al. Among authors: stones sr. Ann Rheum Dis. 2021 Jan;80(1):65-70. doi: 10.1136/annrheumdis-2020-218015. Epub 2020 Aug 11. Ann Rheum Dis. 2021. PMID: 32788400 Free article.
Analysing and reporting of observational data: a systematic review informing the EULAR points to consider when analysing and reporting comparative effectiveness research with observational data in rheumatology.
Lauper K, Kedra J, de Wit M, Fautrel B, Frisell T, Hyrich KL, Iannone F, Machado PM, Ørnbjerg LM, Rotar Z, Santos MJ, Stamm TA, Stones SR, Strangfeld A, Landewé RB, Finckh A, Bergstra SA, Courvoisier DS. Lauper K, et al. Among authors: stones sr. RMD Open. 2021 Nov;7(3):e001818. doi: 10.1136/rmdopen-2021-001818. RMD Open. 2021. PMID: 34789534 Free PMC article.
EULAR points to consider for therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases.
Krieckaert CL, van Tubergen A, Gehin JE, Hernández-Breijo B, Le Mélédo G, Balsa A, Böhm P, Cucnik S, Elkayam O, Goll GL, Hooijberg F, Jani M, Kiely PD, McCarthy N, Mulleman D, Navarro-Compán V, Payne K, Perry ME, Plasencia-Rodriguez C, Stones SR, Syversen SW, de Vries A, Ward KM, Wolbink G, Isaacs JD. Krieckaert CL, et al. Among authors: stones sr. Ann Rheum Dis. 2023 Jan;82(1):65-73. doi: 10.1136/annrheumdis-2022-222155. Epub 2022 May 12. Ann Rheum Dis. 2023. PMID: 35551063
33 results